Top Stock Picks and Market News for Friday: Take-Two Interactive, AT&T, CVS Health, Chinese Listings, Virgin Galactic, Robinhood, GitLab, Blackstone, Albemarle – Wall Street Update

2023-12-05 14:05:00

Main stocks to follow Friday on Wall Street, where futures contracts on the main indices suggest an opening down 0.25% for the Dow Jones .DJI, 0.37% for the Standard & Poor’s 500 .SPX and 0.43% for the Nasdaq .IXIC: * TAKE-TWO INTERACTIVE SOFTWARE TTWO.O fell 4.8% in pre-market trading after the presentation of the trailer for the latest part of its video game “Grand Theft Auto VI” , which will be released in 2025. * AT&T TN has chosen Ericsson ERICb.ST to build a telecommunications network using new cost-reducing Open RAN technology that will cover 70% of its mobile traffic in the United States by the end of 2026, a announced the operator. * CVS HEALTH CVS.N announced Tuesday that it expects adjusted earnings of at least $8.50 per share for next year, in line with Wall Street expectations. The action gained 2.5% in pre-market trading. * Chinese groups listed on Wall Street PDD HOLDINGS PDD.O, JD.COM JD.O and BAIDU BIDU.O fell from 1.8% to 2.2% in pre-market trading after the Moody’s agency lowered its the prospect of China’s rating from “stable” to “negative” due to the country’s debt. * VIRGIN GALACTIC SPCE.N fell 3.6% in pre-market trading after falling 17.5% on Monday following the decision of billionaire Richard Branson to exclude any additional liquidity injection into his space travel company, according to information from the Financial Times. * ROBINHOOD HOOD.O rises 2.4% in pre-market trading, the online brokerage platform having reported an increase in cryptocurrency trading in November while bitcoin BTC = BTSP touched a Monday 20-month high of more than $42,000. * GITLAB GTLB.O soars 14.2% in pre-market trading, the software development platform having published an unexpected adjusted profit in the third quarter against an anticipated net loss according to LSEG data. * BLACKSTONE BX.N is studying the possibility of a sale of Anthos Therapeutics, its biopharmaceutical subsidiary which launched a new generation of anticoagulants in partnership with Novartis NOVN.S, according to sources familiar with the matter. * ALBEMARLE ALB.N – Piper Sandler lowers its recommendation from “neutral” to “underweight”. The stock lost 2.4% in pre-market trading. (Writing by Claude Chendjou, edited by Kate Entringer)
1701793802
#USAStocks #follow #Wall #Street #updated #p.m

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.